APCR Issues Statement on COVID-19

Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Some Caution Over 'People’s Hope' Remdesivir As China Trials Progress

Tue, 03/17/2020 - 6:21pm

Although Gilead’s remdesivir shows promise against the coronavirus, efficacy is not guaranteed, one antiviral company executive tells Scrip, as multiple...

      Related Stories 

Bad For Pharma: Sales Reps And Patients Are Staying Home

Tue, 03/17/2020 - 4:11pm

Industry is limiting face-to-face interactions between sales reps and physicians, and some patients are sitting out visits, amid the COVID-19...

      Related Stories 

Drug Spending Growth Will Decelerate Due To Pricing Pressures, IQVIA Finds

Tue, 03/17/2020 - 2:31pm

Global spending on medicines will continue to increase through 2024, but at a lower rate than the previous five years...

      Related Stories 

Shifting EU Treatment Paradigms In CLL

Tue, 03/17/2020 - 9:05am

The CLL market segment in the EU will now include a first-line combination therapy of AbbVie’s venetoclax and Roche’s obinutuzumab...

      Related Stories 

Granules India Buyback – Ray Of Hope During Coronavirus Turmoil?

Tue, 03/17/2020 - 1:02am

Granules India’s buyback offer seems to be timed right. As the novel coronavirus crisis batters the Indian stock market, a...

      Related Stories 

India Coronavirus Actions: Stock Checks, Kaletra Gx Readiness And Bulk Drugs

Mon, 03/16/2020 - 10:11pm

A string of actions to ensure medicines security and prioritize bulk drug project clearances are underway in India as the...

      Related Stories 

Sanofi And Regeneron Initiate 400-Patient Coronavirus Trial With Kevzara

Mon, 03/16/2020 - 12:07pm

The Phase II/III trial will begin enrolling patients in the US immediately, with Regeneron taking the lead in US development...

      Related Stories 

Redx Set To Be Taken Over By Redmile

Mon, 03/16/2020 - 8:03am

Ex-suitor Yesod seemed keen again but it looks as though Redx Pharma is about to be acquired by Redmile after...

      Related Stories 

Coronavirus Update: Europe Enters Lockdown, Pharma Home Working, Belldegrun Tests Positive

Mon, 03/16/2020 - 2:40am

Governments around Europe take action to shut places of work and schools and impose new border restrictions, as death toll...

      Related Stories 

Pages